Notice of Inventions. If any researcher or research collaborator of the University (collectively, a “Researcher”) has conceived any Invention as a result of the Entrusted Research, the University shall promptly notify the Partner.
Notice of Inventions. If any researcher or research collaborator of either Party (collectively, a “Researcher”) has conceived any Invention as a result of the Collaborative Research, the University or the Partner shall promptly notify the other Party, and shall discuss with that Party regarding the share of ownership and the determination of whether or not to file an application for the Intellectual Property Rights which relate to such Invention.
Notice of Inventions. Each Party will notify the other of the invention, creation, development, or reduction to practice of any Joint Technology, and NVS will promptly notify HMI of the invention, creation, development, or reduction to practice of any HMI Assigned Know-How and HMI Assigned Patent Rights, NVS Program Know-How, and NVS Program Patent Rights, and HMI will promptly notify NVS of the invention, creation, development, or reduction to practice of any HMI Program Know-How, HMI Program Patent Rights, NVS Assigned Know-How, and NVS Assigned Patent Rights. Each Party will ensure that its Affiliates, Sublicensees, and subcontractors enable such disclosure.
Notice of Inventions. Symyx and Bayer shall promptly report to the RFC of each Field any inventions relating to Lead Compounds or Program Technology or Combinatorial Chemistry Technology made in the course of performing the Research Program.
Notice of Inventions. Symyx and Celanese shall report to the RFC of each Active Field any inventions relating to Lead Compounds or Program Technology made in the conduct of the Research Program.
Notice of Inventions. Each party shall promptly disclose to the other, unless prohibited by the Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company's application requesting confidential treatment under Rule 406 of the Securities Act. provisions of any agreement with third parties, all inventions applicable to the development, manufacture or use of NuCleave-TM- Kits for use in the Pharmaceutical Development Field that are conceived, made, developed or acquired in the course of carrying out the Alliance Program by employees or consultants of either of them or their Affiliates, or any third party performing sponsored research for either of the parties, alone or jointly with employees or consultants of the other party or its Affiliates, except, in the case of WATERS, any inventions applicable to instruments or accessories that may be sold or distributed in conjunction with the NuCleave Kits which shall not be required to be disclosed under this Section 11.1.1.
Notice of Inventions and Access to Records of the Research Program. Symyx and TDCC shall report to the Research Committee all inventions relating to Lead Compounds, Derivative Compounds, or Program Technology made in the course of performing the Research Program. During the Research Program Term and for three (3) years thereafter, each of TDCC and Symyx shall make available to the other party upon request research records pertaining to such inventions as may be reasonably required to exercise any rights of a party arising pursuant to this Agreement. Such records and the information disclosed therein shall be deemed Confidential Information of the party providing such records for inspection subject to the obligations and conditions in Article 9. Upon request and tender of payment for the actual cost in providing copies, Symyx and/or TDCC, as appropriate, shall provide to the requesting party legible copies of such records as are reasonably required.
Notice of Inventions. Symyx and ExxonMobil or its Designee shall report to the respective Research Committee for a Project all inventions relating to Lead Materials or Program Technology made as part of performing the Research Program. Prior to selection of the Royalty-Bearing Projects pursuant to Section 8.07, ExxonMobil or its Designee shall disclose to Symyx all inventions relating to Derivative Materials. After selection of the Royalty-Bearing Projects, ExxonMobil or its Designee shall disclose to Symyx all inventions relating to Derivative Materials derived from Lead Materials identified by Symyx for use in the *, but only until expiration or termination of the applicable royalty obligation.
Notice of Inventions. Each party shall promptly notify and fully -------------------- disclose in writing all ideas and developments, whether or nor patentable, conceived or reduced to practice by either party in connection with the performance of the Research Program. The parties shall consult with each other to review such development and determine its patentability.
Notice of Inventions. Institution shall promptly notify Immunicon of any Invention made by it during the course of the Research Program.
